AVOQ, LLC

Lobbying for NOVO NORDISK INC. · Pharmaceutical company

Filing 1st Quarter - Termination

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

New Jersey

Representation ended

Feb 1, 2026

The registrant reported terminating its work for this client.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Issues related to obesity; Issues related to medication affordability and access

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.